Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-18

Clinical Trial Update: Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III

View source ↗

Summary

This clinical trial update summarizes the natural history, disease progression, and long-term neurologic sequelae observed in Ebola virus disease survivors from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Virus Disease | Status: COMPLETED